Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Full-year 2023 revenue of $20.4 million reflects a decrease from 2022 revenue of $7.3 due to a managed decrease in B2C and strategic milestone revenue as the.
BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2023 tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital health market, today announced that management will participate in the Cowen.
Expecting nearly doubling Dario s pro forma revenues in 2023
Acquisition is immediately accretive to revenue and gross margins and expected to accelerate path to profitability
Concurrent with the.